These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15286811)

  • 21. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B].
    Tu H; Gao HF; Ma GH; Liu Y
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1249-52. PubMed ID: 16796883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
    Bortolami M; Kotsafti A; Cardin R; Farinati F
    J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam.
    Toan NL; Song le H; Kremsner PG; Duy DN; Binh VQ; Koeberlein B; Kaiser S; Kandolf R; Torresi J; Bock CT
    Hepatology; 2006 Jun; 43(6):1375-84. PubMed ID: 16729315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetics factors determining predisposition to chronic course of virus hepatitis and fibrosis in liver].
    Goncharova IA; Beloborodova EV; Freĭdin MB; Beloborodova EI; Chernogoriuk GE; Puzyrev VP
    Mol Biol (Mosk); 2008; 42(2):238-41. PubMed ID: 18610831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease.
    Suneetha PV; Sarin SK; Goyal A; Kumar GT; Shukla DK; Hissar S
    J Hepatol; 2006 May; 44(5):856-63. PubMed ID: 16545485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: a study from tertiary care hospital.
    Chakravarti A; Verma V; Jain M; Kar P
    Trop Gastroenterol; 2005; 26(4):183-7. PubMed ID: 16737047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma.
    Feitelson MA
    Cancer Lett; 2006 Jul; 239(1):10-20. PubMed ID: 16154256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses.
    Rehermann B
    Semin Liver Dis; 2007 May; 27(2):152-60. PubMed ID: 17520515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma and hepatitis B virus.
    Chan HL; Sung JJ
    Semin Liver Dis; 2006 May; 26(2):153-61. PubMed ID: 16673293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical examinations based on nucleic acids of hepatitis viruses].
    Tanaka Y; Mizokami M
    Rinsho Byori; 2006 Nov; 54(11):1164-71. PubMed ID: 17240839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronic hepatitis B virus infection].
    Carretero C; Herráiz M
    An Sist Sanit Navar; 2004; 27 Suppl 2():27-32. PubMed ID: 15381940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection.
    Ramezani A; Hasanjani Roshan MR; Kalantar E; Eslamifar A; Banifazl M; Taeb J; Aghakhani A; Gachkar L; Velayati AA
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1716-21. PubMed ID: 18761557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progressive liver injury in chronic hepatitis C infection is related to altered cellular immune response and to different citokine profile.
    Cecere A; Marotta F; Vangieri B; Tancredi L; Gattoni A
    Panminerva Med; 2004 Sep; 46(3):171-87. PubMed ID: 15510086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005.
    Yim HJ; Lok AS
    Hepatology; 2006 Feb; 43(2 Suppl 1):S173-81. PubMed ID: 16447285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C.
    Falasca K; Ucciferri C; Dalessandro M; Zingariello P; Mancino P; Petrarca C; Pizzigallo E; Conti P; Vecchiet J
    Ann Clin Lab Sci; 2006; 36(2):144-50. PubMed ID: 16682509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of chronic hepatitis B virus infection: a new era of disease control.
    Farrell GC; Teoh NC
    Intern Med J; 2006 Feb; 36(2):100-13. PubMed ID: 16472264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.